1043-21-6

Basic information

• Product Name: Pirenoxine
• Synonyms: 1-Hydroxy-5-oxo-5H-pyrido[3,2-]phenoxazine-3-carboxylicacid;Bernetine;catalin;PIRENOXINE;1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylic acid;1-Hydroxy-3-carboxy-5H-pyrido[3,2-a]phenoxazin-5-one;1-Hydroxy-5H-pyrido[3,2-a]phenoxazin-5-one-3-carboxylic acid;5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-
• CAS NO: 1043-21-6
• Molecular Formula: C16H8N2O5
• Molecular Weight: 308.25
• EINECS: 213-872-4
• Mol File: 1043-21-6.mol
• Article Data: 0

Chemical Properties

• Melting Point: 247-248°C
• Boiling Point: 515.8 °C at 760 mmHg
• Flash Point: 265.7 °C
• Appearance: /
• Density: 1.7 g/cm³
• Vapor Pressure: 1.83E-11mmHg at 25°C
• Refractive Index: 1.793
• Storage Temp.: -20°C Freezer
• Solubility: Aqueous Base (Slightly)
• CAS DataBase Reference: Pirenoxine(CAS DataBase Reference)
• NIST Chemistry Reference: Pirenoxine(1043-21-6)
• EPA Substance Registry System: Pirenoxine(1043-21-6)

Safety Data

• Hazardous Substances Data: 1043-21-6(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 1043-21-6 differently. You can refer to the following data:
1. antiviral
2. Pirenoxine, is a medication used in the possible treatment and prevention of cataracts.

InChI:InChI=1/C16H8N2O5/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12/h1-6H,(H,18,19)(H,21,22)

Related news

Interaction between Pirenoxine (cas 1043-21-6) and bovine serum albumin in aqueous solution07/23/2019

This work concerns the interaction of prenoxine sodium (PRX) and bovine serum albumin (BSA), which was conducted by spectroscopic means: fluorescence spectra, ultraviolet–visible spectra (UV–vis) and circular dichroism spectra (CD spectra) in physiological conditions. The results revealed the ...detailed

Pirenoxine (cas 1043-21-6) prevents oxidative effects of argon fluoride excimer laser irradiation in rabbit corneas: biochemical, histological and cytofluorimetric evaluations07/22/2019

The production of reactive oxygen species (ROS) associated with excimer laser irradiation is recognized as a possible cause of corneal haze following photorefractive keratectomy (PRK). Our work was aimed at investigating in vitro the oxidative effects induced by subablative laser fluences and at...detailed